Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models

Summary: Background: Vaccines in emergency use are efficacious against COVID-19, yet vaccine-induced prevention against nasal SARS-CoV-2 infection remains suboptimal. Methods: Since mucosal immunity is critical for nasal prevention, we investigated the efficacy of an intramuscular PD1-based recepto...

Full description

Bibliographic Details
Main Authors:	Runhong Zhou, Pui Wang, Yik-Chun Wong, Haoran Xu, Siu-Ying Lau, Li Liu, Bobo Wing-Yee Mok, Qiaoli Peng, Na Liu, Kin-Fai Woo, Shaofeng Deng, Rachel Chun-Yee Tam, Haode Huang, Anna Jinxia Zhang, Dongyan Zhou, Biao Zhou, Chun-Yin Chan, Zhenglong Du, Dawei Yang, Ka-Kit Au, Kwok-Yung Yuen, Honglin Chen, Zhiwei Chen
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	EBioMedicine
Subjects:	SARS-CoV-2 Receptor binding domain Mucosal immunity Nasal prevention PD1-based DNA vaccine Live-attenuated influenza-based vaccine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396421005569

Similar Items

Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines
by: Pui Wang, et al.
Published: (2019-10-01)

Crosslinked chitosan microparticles as a safe and efficient DNA carrier for intranasal vaccination against cutaneous leishmaniasis
by: Beatriz L.S. Costa Souza, et al.
Published: (2023-12-01)

An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters
by: Shaofeng Deng, et al.
Published: (2023-04-01)

Community-based participatory research (CBPR) approaches in vaccination promotion: a scoping review
by: Yan Zhang, et al.
Published: (2024-11-01)

Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease
by: Seok-Chan Park, et al.
Published: (2023-07-01)

Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia
by: Emel Sen-Kilic, et al.
Published: (2019-10-01)

Vaccine approaches to treat urothelial cancer
by: Giulia Claire Giudice, et al.
Published: (2024-12-01)

Schoolteachers’ experiences of implementing school-based vaccination programs against human papillomavirus in a Chinese community: a qualitative study
by: Judy Yuen-man Siu, et al.
Published: (2019-11-01)

A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma
by: Alireza Tojjari, et al.
Published: (2023-08-01)

Phage based vaccine: A novel strategy in prevention and treatment
by: Sharareh Mohammad Hasani, et al.
Published: (2023-09-01)

The potential of plant-based vaccines
by: Mahdi Ghatreh Samani
Published: (2022-11-01)

Current Status of Intranasal COVID-19 Vaccine, its Usage and Efficacy: A Narrative Review
by: Ratan Tandon, et al.
Published: (2023-05-01)

Pharmacists’ Willingness to Offer Vaccination Services: A Systematic Review and Meta-Analysis
by: Arit Udoh, et al.
Published: (2024-06-01)

Aspects of Phage-Based Vaccines for Protein and Epitope Immunization
by: Marco Palma
Published: (2023-02-01)

New Technologies for Influenza Vaccines
by: Steven Rockman, et al.
Published: (2020-11-01)

Vaccination in the immunotherapy of glioblastoma
by: Ziren Kong, et al.
Published: (2018-02-01)

Cost-effectiveness analysis has to consider all available evidence when informing inputs
by: Fabián P. Alvarez, et al.
Published: (2021-03-01)

Single-cycle adenovirus vectors in the current vaccine landscape
by: Michael Barry
Published: (2018-02-01)

A Review of Protein-Based COVID-19 Vaccines: From Monovalent to Multivalent Formulations
by: Gui Qian, et al.
Published: (2024-05-01)

Applications of polymer-based nanoparticles in vaccine field
by: Guo Sihan, et al.
Published: (2019-11-01)

Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons
by: Constantina Boikos, et al.
Published: (2022-06-01)

Intranasal (IN) COVID-19 vaccines - a breakthrough
by: Ramandeep Singh Gambhir, et al.
Published: (2023-03-01)

Use of the PRECEDE-PROCEED Model in Piloting Vaccine Promotion and Infection Self-Protection: Intervention Development and Effectiveness Examination
by: Yao Jie Xie, et al.
Published: (2024-08-01)

An RNA-Scaffold Protein Subunit Vaccine for Nasal Immunization
by: Joy-Yan Lam, et al.
Published: (2023-09-01)

Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
by: Yongqiang Zhao, et al.
Published: (2025-02-01)

Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases
by: Giuseppe Stefanetti, et al.
Published: (2022-01-01)

Meningococcal Vaccines: Current Status and Emerging Strategies
by: Pumtiwitt C. McCarthy, et al.
Published: (2018-02-01)

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
by: Vivek P. Chavda, et al.
Published: (2023-02-01)

COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
by: Aleksandra Anna Zasada, et al.
Published: (2023-08-01)

Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis
by: Chiara Bellini, et al.
Published: (2020-12-01)

Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting
by: Fiona Ecarnot, et al.
Published: (2019-12-01)

Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
by: Sanchita Kar, et al.
Published: (2022-04-01)

Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters
by: Yongjun Sui, et al.
Published: (2025-02-01)

Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier
by: Xiaoyi Gao, et al.
Published: (2021-12-01)

DEVELOPMENT OF STANDARD PROTOCOLS FOR PREPARATION AND EVALUATION OF LIVER HOMOGENATE VACCINES AGAINST HYDROPERICARDIUM SYNDROME VIRUS IN POULTRY
by: SAHIDULLAH, SADEEQ-UR-RAHMAN, M. RABBANI1, M. KAMAL SHAH2, S. NASEEM1, S. H. KHAN2 AND K. MUHAMMAD1
Published: (2008-12-01)

Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US
by: Stephen I. Pelton, et al.
Published: (2024-12-01)

Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics
by: Man Cui, et al.
Published: (2024-08-01)

MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system
by: Yoshikazu Yuki, et al.
Published: (2024-03-01)

Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness
by: Steven Rockman, et al.
Published: (2022-12-01)

Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
by: Abdulla Watad, et al.
Published: (2021-04-01)